Literature DB >> 29743375

Expression Levels of Glycoprotein O (gO) Vary between Strains of Human Cytomegalovirus, Influencing the Assembly of gH/gL Complexes and Virion Infectivity.

Le Zhang1,2,3, Momei Zhou4, Richard Stanton5,6, Jeremy Kamil7,8, Brent J Ryckman9,10,2,3.   

Abstract

The tropism of human cytomegalovirus (HCMV) is influenced by the envelope glycoprotein complexes gH/gL/gO and gH/gL/UL128-131. During virion assembly, gO and the UL128-131 proteins compete for binding to gH/gL in the endoplasmic reticulum (ER). This assembly process clearly differs among strains, since Merlin (ME) virions contain abundant gH/gL/UL128-131 and little gH/gL/gO, whereas TR contains much higher levels of total gH/gL, mostly in the form of gH/gL/gO, but much lower levels of gH/gL/UL128-131 than ME. Remaining questions include (i) what are the mechanisms behind these assembly differences, and (ii) do differences reflect in vitro culture adaptations or natural genetic variations? Since the UL74(gO) open reading frame (ORF) differs in 25% of amino acids between TR and ME, we analyzed recombinant viruses in which the UL74(gO) ORF was swapped. TR virions were >40-fold more infectious than ME. Transcriptional repression of UL128-131 enhanced the infectivity of ME to the level of TR, despite still far lower levels of gH/gL/gO. Swapping the UL74(gO) ORF had no effect on either TR or ME. A quantitative immunoprecipitation approach revealed that gH/gL expression levels were within 4-fold between TR and ME, but the gO expression level was 20-fold lower for ME, which suggested differences in mRNA transcription, translation, or rapid ER-associated degradation of gO. trans-Complementation of gO expression during ME replication gave a 6-fold enhancement of infectivity beyond the 40-fold effect of UL128-131 repression alone. Overall, strain variations in the assembly of gH/gL complexes result from differences in the expression of gO and UL128-131, and selective advantages for reduced UL128-131 expression during fibroblast propagation are much stronger than those for higher gO expression.IMPORTANCE Specific genetic differences between independently isolated HCMV strains may result from purifying selection on de novo mutations arising during propagation in culture or random sampling among the diversity of genotypes present in clinical specimens. Results presented indicate that while reduced UL128-131 expression may confer a powerful selective advantage during cell-free propagation of HCMV in fibroblast cultures, selective pressures for increased gO expression are much weaker. Thus, variation in gO expression among independent strains may represent natural genotype variability present in vivo This may have important implications for virus-host interactions, such as immune recognition, and underscores the value of studying molecular mechanisms of replication using multiple HCMV strains.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  genetic diversity; glycoproteins; human cytomegalovirus; tropism

Mesh:

Substances:

Year:  2018        PMID: 29743375      PMCID: PMC6052298          DOI: 10.1128/JVI.00606-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  49 in total

1.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.

Authors:  Gang Li; Christopher C Nguyen; Brent J Ryckman; William J Britt; Jeremy P Kamil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

3.  High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.

Authors:  Steven Sijmons; Kim Thys; Mirabeau Mbong Ngwese; Ellen Van Damme; Jan Dvorak; Marnix Van Loock; Guangdi Li; Ruth Tachezy; Laurent Busson; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism.

Authors:  Dai Wang; Thomas Shenk
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Identification of the major capsid protein gene of human cytomegalovirus.

Authors:  M Chee; S A Rudolph; B Plachter; B Barrell; G Jahn
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 6.  Fusing structure and function: a structural view of the herpesvirus entry machinery.

Authors:  Sarah A Connolly; Julia O Jackson; Theodore S Jardetzky; Richard Longnecker
Journal:  Nat Rev Microbiol       Date:  2011-04-11       Impact factor: 60.633

7.  Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection.

Authors:  Min Hua Luo; Philip H Schwartz; Elizabeth A Fortunato
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

8.  Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells.

Authors:  Brent J Ryckman; Barb L Rainish; Marie C Chase; Jamie A Borton; Jay A Nelson; Michael A Jarvis; David C Johnson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells.

Authors:  Cora Stegmann; Daniel Hochdorfer; Diana Lieber; Narmadha Subramanian; Dagmar Stöhr; Kerstin Laib Sampaio; Christian Sinzger
Journal:  PLoS Pathog       Date:  2017-04-12       Impact factor: 6.823

10.  The contribution of pUL74 to growth of human cytomegalovirus is masked in the presence of RL13 and UL128 expression.

Authors:  Kerstin Laib Sampaio; Cora Stegmann; Ilija Brizic; Barbara Adler; Richard J Stanton; Christian Sinzger
Journal:  J Gen Virol       Date:  2016-04-06       Impact factor: 5.141

View more
  14 in total

1.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Influence of Human Cytomegalovirus Glycoprotein O Polymorphism on the Inhibitory Effect of Soluble Forms of Trimer- and Pentamer-Specific Entry Receptors.

Authors:  Nadja Brait; Tanja Stögerer; Julia Kalser; Barbara Adler; Ines Kunz; Max Benesch; Barbara Kropff; Michael Mach; Elisabeth Puchhammer-Stöckl; Irene Görzer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

3.  Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.

Authors:  Le Zhang Day; Cora Stegmann; Eric P Schultz; Jean-Marc Lanchy; Qin Yu; Brent J Ryckman
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

4.  Distinct Properties of Human Cytomegalovirus Strains and the Appropriate Choice of Strains for Particular Studies.

Authors:  Giada Frascaroli; Christian Sinzger
Journal:  Methods Mol Biol       Date:  2021

5.  Human Cytomegalovirus Tropism Modulator UL148 Interacts with SEL1L, a Cellular Factor That Governs Endoplasmic Reticulum-Associated Degradation of the Viral Envelope Glycoprotein gO.

Authors:  Christopher C Nguyen; Mohammed N A Siddiquey; Hongbo Zhang; Gang Li; Jeremy P Kamil
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  The Human Cytomegalovirus Protein UL116 Interacts with the Viral Endoplasmic-Reticulum-Resident Glycoprotein UL148 and Promotes the Incorporation of gH/gL Complexes into Virions.

Authors:  Mohammed N A Siddiquey; Eric P Schultz; Qin Yu; Diego Amendola; Giacomo Vezzani; Dong Yu; Domenico Maione; Jean-Marc Lanchy; Brent J Ryckman; Marcello Merola; Jeremy P Kamil
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

7.  In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.

Authors:  Husam Taher; Eisa Mahyari; Craig Kreklywich; Luke S Uebelhoer; Matthew R McArdle; Matilda J Moström; Amruta Bhusari; Michael Nekorchuk; Xiaofei E; Travis Whitmer; Elizabeth A Scheef; Lesli M Sprehe; Dawn L Roberts; Colette M Hughes; Kerianne A Jackson; Andrea N Selseth; Abigail B Ventura; Hillary C Cleveland-Rubeor; Yujuan Yue; Kimberli A Schmidt; Jason Shao; Paul T Edlefsen; Jeremy Smedley; Timothy F Kowalik; Richard J Stanton; Michael K Axthelm; Jacob D Estes; Scott G Hansen; Amitinder Kaur; Peter A Barry; Benjamin N Bimber; Louis J Picker; Daniel N Streblow; Klaus Früh; Daniel Malouli
Journal:  PLoS Pathog       Date:  2020-11-24       Impact factor: 7.464

8.  Distribution of the CMV glycoprotein gH/gL/gO and gH/gL/pUL128/pUL130/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally.

Authors:  Edyta Paradowska; Agnieszka Jabłońska; Mirosława Studzińska; Beata Kasztelewicz; Małgorzata Wiśniewska-Ligier; Katarzyna Dzierżanowska-Fangrat; Teresa Woźniakowska-Gęsicka; Justyna Czech-Kowalska
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

9.  Expression Levels of Glycoprotein O (gO) Vary between Strains of Human Cytomegalovirus, Influencing the Assembly of gH/gL Complexes and Virion Infectivity.

Authors:  Le Zhang; Momei Zhou; Richard Stanton; Jeremy Kamil; Brent J Ryckman
Journal:  J Virol       Date:  2018-07-17       Impact factor: 6.549

10.  The Human Cytomegalovirus Nonstructural Glycoprotein UL148 Reorganizes the Endoplasmic Reticulum.

Authors:  Hongbo Zhang; Clarissa Read; Christopher C Nguyen; Mohammed N A Siddiquey; Chaowei Shang; Cameron M Hall; Jens von Einem; Jeremy P Kamil
Journal:  mBio       Date:  2019-12-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.